Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Invested Capital (2018 - 2022)

NovaBridge Biosciences (NBP) has disclosed Invested Capital for 5 consecutive years, with $411.8 million as the latest value for Q4 2022.

  • Quarterly Invested Capital fell 42.26% to $411.8 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $411.8 million through Dec 2022, down 42.26% year-over-year, with the annual reading at $411.8 million for FY2022, 42.26% down from the prior year.
  • Invested Capital for Q4 2022 was $411.8 million at NovaBridge Biosciences, down from $713.2 million in the prior quarter.
  • The five-year high for Invested Capital was $849.1 million in Q4 2020, with the low at -$281.6 million in Q4 2019.
  • Average Invested Capital over 5 years is $313.2 million, with a median of $411.8 million recorded in 2022.
  • The sharpest move saw Invested Capital crashed 122.48% in 2019, then skyrocketed 401.54% in 2020.
  • Over 5 years, Invested Capital stood at -$126.6 million in 2018, then tumbled by 122.48% to -$281.6 million in 2019, then surged by 401.54% to $849.1 million in 2020, then decreased by 16.01% to $713.2 million in 2021, then plummeted by 42.26% to $411.8 million in 2022.
  • According to Business Quant data, Invested Capital over the past three periods came in at $411.8 million, $713.2 million, and $849.1 million for Q4 2022, Q4 2021, and Q4 2020 respectively.